LINC02090

Across TCGA pan-cancer cohorts, LINC02090 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC02090 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher LINC02090 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02090 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BRCA show a favorable association.

ACC, HNSC, and MESO are the cancer types where LINC02090 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.624	<.001	117	view →
HNSC	DFS	Tertile	III,IV	0.531	0.288	.006	42	view →
MESO	OS	Tertile	IV	0.129	0.679	<.001	36	view →
THYM	DFS	Tertile	III,IV	0.317	0.913	<.001	36	view →
BRCA	OS	Tertile	All	0.993	0.955	.004	30	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	21	view →
BLCA	OS	Tertile	IV	0.215	0.610	.004	18	view →
KIRC	DFS	Tertile	IV	0.689	0.213	.012	18	view →
CHOL	DFS	Tertile	All	1.000	0.329	.020	18	view →
LIHC	DFS	Tertile	III,IV	0.122	0.349	.009	18	view →
READ	OS	Tertile	All	0.257	0.764	.003	18	view →
DLBC	DFS	Median	IV	0.128	1.000	.017	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC02090–ACC (DFS)

Open the ACC breakdown →